Palisade Bio Reports Positive Phase 1 Results for PALI-2108 PALI Stock News
| PALI Stock | USD 1.02 0.02 1.92% |
Under 62% of Palisade Bio's investor base is looking to short. The analysis of overall sentiment of trading Palisade Bio stock suggests that many investors are alarmed at this time. Palisade Bio's investing sentiment shows overall attitude of investors towards Palisade Bio.
Palisade Bio has released encouraging topline results from its Phase 1 trials of PALI-2108, an innovative treatment targeting fibrostenotic Crohns disea
Read at gurufocus.com
 |
Palisade Bio Fundamental Analysis
We analyze Palisade Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Palisade Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Palisade Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Palisade Bio is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Palisade Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Palisade Bio stock to make a market-neutral strategy. Peer analysis of Palisade Bio could also be used in its relative valuation, which is a method of valuing Palisade Bio by comparing valuation metrics with similar companies.
Peers
Palisade Bio Related Equities
| ZURA | Zura Bio | 7.53 | ||||
| ATNF | 180 Life | 5.66 | ||||
| ENSC | Ensysce Biosciences | 3.72 | ||||
| CDIO | Cardio Diagnostics | 0.50 | ||||
| PHIO | Phio Pharmaceuticals | 0.84 | ||||
| MTVA | MetaVia | 1.64 | ||||
| QNRX | Quoin Pharmaceuticals | 1.76 | ||||
| KPRX | Kiora Pharmaceuticals | 2.31 | ||||
| SONN | Sonnet Biotherapeutics | 5.69 | ||||
| NUWE | Nuwellis | 21.18 |
Complementary Tools for Palisade Stock analysis
When running Palisade Bio's price analysis, check to measure Palisade Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Palisade Bio is operating at the current time. Most of Palisade Bio's value examination focuses on studying past and present price action to predict the probability of Palisade Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Palisade Bio's price. Additionally, you may evaluate how the addition of Palisade Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stocks Directory Find actively traded stocks across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets |